Effects of losartan on pressure overload-induced cardiac gene expression profiling in rats

Jinliang Li, Ping Li, Xinheng Feng, Zhaoping Li, Rong Hou, Chide Han, Youyi Zhang

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

1. In the present study, the effects of losartan on myocardial gene expression changes following cardiac hypertrophy were investigated. 2. Male Wistar rats were randomized to receive 5 or 30 mg/kg per day losartan (i.p.) 1 day after suprarenal abdominal aortic constriction. Two weeks later, cardiac morphology and function were recorded with echocardiography and mean arterial central pressure was measured using carotid catheters. Myocardial gene expression was assessed with cDNA microarrays. 3. The ratios of left ventricular weights to bodyweights, the posterior thickness of the left ventricle and mean arterial central pressure were significantly increased by aortic constriction and attenuated by losartan in a dose-related manner. Genes in different functional categories were regulated in pressure overload-induced cardiac hypertrophy and the majority of changes in gene expression were inhibited by losartan in a dose-dependent manner. 4. However, there were still some genes that were unaffected by losartan, even at a higher dose. In contrast, losartan, especially at a lower dose, was able to induce changes in the expression of several additional genes that were unregulated in simple aortic constriction. 5. In conclusion, losartan is able to inhibit pressure overload-induced cardiac hypertrophy, as well as the majority of pressure overload-related changes in gene expression. The genes that remained unaffected or those that were additionally induced by losartan are likely to be new targets for investigation or therapy.

Original languageEnglish
Pages (from-to)827-832
Number of pages6
JournalClinical and Experimental Pharmacology and Physiology
Volume30
Issue number11
DOIs
StatePublished - Nov 1 2003
Externally publishedYes

Fingerprint

Losartan
Gene Expression Profiling
Pressure
Cardiomegaly
Constriction
Gene Expression
Genes
Arterial Pressure
Oligonucleotide Array Sequence Analysis
Heart Ventricles
Echocardiography
Wistar Rats
Catheters
Weights and Measures

Keywords

  • Cardiac hypertrophy
  • cDNA microarray
  • Gene expression
  • Losartan
  • Pressure overload

ASJC Scopus subject areas

  • Physiology
  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Effects of losartan on pressure overload-induced cardiac gene expression profiling in rats. / Li, Jinliang; Li, Ping; Feng, Xinheng; Li, Zhaoping; Hou, Rong; Han, Chide; Zhang, Youyi.

In: Clinical and Experimental Pharmacology and Physiology, Vol. 30, No. 11, 01.11.2003, p. 827-832.

Research output: Contribution to journalArticle

Li, Jinliang ; Li, Ping ; Feng, Xinheng ; Li, Zhaoping ; Hou, Rong ; Han, Chide ; Zhang, Youyi. / Effects of losartan on pressure overload-induced cardiac gene expression profiling in rats. In: Clinical and Experimental Pharmacology and Physiology. 2003 ; Vol. 30, No. 11. pp. 827-832.
@article{c13be7f60f5c4a289248e4eb4ca8538f,
title = "Effects of losartan on pressure overload-induced cardiac gene expression profiling in rats",
abstract = "1. In the present study, the effects of losartan on myocardial gene expression changes following cardiac hypertrophy were investigated. 2. Male Wistar rats were randomized to receive 5 or 30 mg/kg per day losartan (i.p.) 1 day after suprarenal abdominal aortic constriction. Two weeks later, cardiac morphology and function were recorded with echocardiography and mean arterial central pressure was measured using carotid catheters. Myocardial gene expression was assessed with cDNA microarrays. 3. The ratios of left ventricular weights to bodyweights, the posterior thickness of the left ventricle and mean arterial central pressure were significantly increased by aortic constriction and attenuated by losartan in a dose-related manner. Genes in different functional categories were regulated in pressure overload-induced cardiac hypertrophy and the majority of changes in gene expression were inhibited by losartan in a dose-dependent manner. 4. However, there were still some genes that were unaffected by losartan, even at a higher dose. In contrast, losartan, especially at a lower dose, was able to induce changes in the expression of several additional genes that were unregulated in simple aortic constriction. 5. In conclusion, losartan is able to inhibit pressure overload-induced cardiac hypertrophy, as well as the majority of pressure overload-related changes in gene expression. The genes that remained unaffected or those that were additionally induced by losartan are likely to be new targets for investigation or therapy.",
keywords = "Cardiac hypertrophy, cDNA microarray, Gene expression, Losartan, Pressure overload",
author = "Jinliang Li and Ping Li and Xinheng Feng and Zhaoping Li and Rong Hou and Chide Han and Youyi Zhang",
year = "2003",
month = "11",
day = "1",
doi = "10.1046/j.1440-1681.2003.03917.x",
language = "English",
volume = "30",
pages = "827--832",
journal = "Clinical and Experimental Pharmacology and Physiology",
issn = "0305-1870",
publisher = "Wiley-Blackwell",
number = "11",

}

TY - JOUR

T1 - Effects of losartan on pressure overload-induced cardiac gene expression profiling in rats

AU - Li, Jinliang

AU - Li, Ping

AU - Feng, Xinheng

AU - Li, Zhaoping

AU - Hou, Rong

AU - Han, Chide

AU - Zhang, Youyi

PY - 2003/11/1

Y1 - 2003/11/1

N2 - 1. In the present study, the effects of losartan on myocardial gene expression changes following cardiac hypertrophy were investigated. 2. Male Wistar rats were randomized to receive 5 or 30 mg/kg per day losartan (i.p.) 1 day after suprarenal abdominal aortic constriction. Two weeks later, cardiac morphology and function were recorded with echocardiography and mean arterial central pressure was measured using carotid catheters. Myocardial gene expression was assessed with cDNA microarrays. 3. The ratios of left ventricular weights to bodyweights, the posterior thickness of the left ventricle and mean arterial central pressure were significantly increased by aortic constriction and attenuated by losartan in a dose-related manner. Genes in different functional categories were regulated in pressure overload-induced cardiac hypertrophy and the majority of changes in gene expression were inhibited by losartan in a dose-dependent manner. 4. However, there were still some genes that were unaffected by losartan, even at a higher dose. In contrast, losartan, especially at a lower dose, was able to induce changes in the expression of several additional genes that were unregulated in simple aortic constriction. 5. In conclusion, losartan is able to inhibit pressure overload-induced cardiac hypertrophy, as well as the majority of pressure overload-related changes in gene expression. The genes that remained unaffected or those that were additionally induced by losartan are likely to be new targets for investigation or therapy.

AB - 1. In the present study, the effects of losartan on myocardial gene expression changes following cardiac hypertrophy were investigated. 2. Male Wistar rats were randomized to receive 5 or 30 mg/kg per day losartan (i.p.) 1 day after suprarenal abdominal aortic constriction. Two weeks later, cardiac morphology and function were recorded with echocardiography and mean arterial central pressure was measured using carotid catheters. Myocardial gene expression was assessed with cDNA microarrays. 3. The ratios of left ventricular weights to bodyweights, the posterior thickness of the left ventricle and mean arterial central pressure were significantly increased by aortic constriction and attenuated by losartan in a dose-related manner. Genes in different functional categories were regulated in pressure overload-induced cardiac hypertrophy and the majority of changes in gene expression were inhibited by losartan in a dose-dependent manner. 4. However, there were still some genes that were unaffected by losartan, even at a higher dose. In contrast, losartan, especially at a lower dose, was able to induce changes in the expression of several additional genes that were unregulated in simple aortic constriction. 5. In conclusion, losartan is able to inhibit pressure overload-induced cardiac hypertrophy, as well as the majority of pressure overload-related changes in gene expression. The genes that remained unaffected or those that were additionally induced by losartan are likely to be new targets for investigation or therapy.

KW - Cardiac hypertrophy

KW - cDNA microarray

KW - Gene expression

KW - Losartan

KW - Pressure overload

UR - http://www.scopus.com/inward/record.url?scp=0345167081&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345167081&partnerID=8YFLogxK

U2 - 10.1046/j.1440-1681.2003.03917.x

DO - 10.1046/j.1440-1681.2003.03917.x

M3 - Article

C2 - 14678244

AN - SCOPUS:0345167081

VL - 30

SP - 827

EP - 832

JO - Clinical and Experimental Pharmacology and Physiology

JF - Clinical and Experimental Pharmacology and Physiology

SN - 0305-1870

IS - 11

ER -